Han sido publicados en diversas revistas internacionales derivados de los proyectos y becas concedidos por la F.L.L. Destacamos, entre otros, los siguientes:
- Comprehensive genomic profiling of a large cohort of acute myeloid leukemia to dissect its genomic and phenotypic complexity. E Papaemmanuil, M Gerstung, R Schlenk, L Bullinger, P Paschka, G Verena, N Bolli, V Teleanu, C-H Köhne, G Held, Brossart, M Ringhoffer, H Horst, M Heuser, F Thol, B Schlegelberger, U Germing, G Arnold, K Döhner, H Döhner, P Campbell. EHA Learning Center. Jun 14, 2015; 103179.
- Sirolimus, Tacrolimus and Low-dose Methotrexate Based Graft-Versus-Host Disease Prophylaxis After non-Ablative or Reduced Intensity Conditioning in Related and Unrelated Donor Allogeneic Hematopoietic Cell Transplant. Ceberio I, Devlin SM, Sauter C, Barker JN, Castro-Malaspina H, Giralt S, Ponce DM, Lechner L, Maloy MA, Goldberg JD, Perales MA. Leuk Lymphoma. 2015 Mar; 56(3):663-70.
- The Role of Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma: Guidelines from the American Society for Blood and Marrow Transplantation. Perales MA, Ceberio I, Armand P et al. Biol Blood Marrow Transplant. 2015 Mar 12. pii: S1083-8791(15)00152-4.
- Novel CTCF Binding at a Site in Exon1A of BCL6 is Associated With Active Histone Marks and a Transcriptionally Active Locus. Batlle-López A1, Cortiguera MG1, Rosa-Garrido M2, Blanco R2, del Cerro E3, Torrano V2, Wagner SD4, Delgado MD2. Oncogene. 2015 Jan 8; 34(2):246-56. doi: 10.1038/onc.2013.535. Epub 2013 Dec 23.
- A phase II Study of a Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell Lymphoid Malignancies: Favorably Durable Event-free Survival in Chemosensitive Patients.Sauter CS, Barker JN, Lechner L, Zheng J, Devlin SM, Papadopoulos EB, Perales MA, Jakubowski AA, Goldberg JD, Koehne G, Ceberio I, Giralt S, Zelenetz AD, Moskowitz CH, Castro-Malaspina H. Biol Blood Marrow Transplant. 2014 Mar; 20 (3):354-60.
- PTCH1 Expression at Diagnosis Predicts Imatinib Failure in Chronic Myeloid Leukaemia Patients in Chronic Phase. Alonso-Dominguez JM1, Grinfeld J, Alikian M, Marin D, Reid A, Daghistani M, Hedgley C, O'Brien S, Clark RE, Apperley J, Foroni L, Gerrard G. American Journal of Hematology. 2014 Sep 22. doi: 10.1002/ajh.23857. Gracias a la Beca «Marcos Fernández».
- Anti-CCR7 Therapy Exerts a Potent Anti-tumor Activity in a Xenograft Model of Human Mantle Cell Lymphoma. Somovilla-Crespo et al. Journal of Hematology & Oncology 2013, 6:89. Gracias a la Beca «Marcos Fernández».
- Quantitative Assessment of T Cell Repertoire Recovery After Hematopoietic Stem Cell Transplantation. Van Heijst JW, Ceberio I, Lipuma LB, Samilo DW, Wasilewski GD, Gonzales AM, Nieves JL, van den Brink MR, Perales MA, Pamer EG. Nat Med. 2013 Mar; 19(3):372-7. Gracias a la Beca «Marcos Fernández».
- A Phase II Study of a Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell Lymphoid Malignancies: Favorably Durable Event-Free Survival in Chemosensitive Patients. Sauter CS, Barker JN, Lechner L, Zheng J, Devlin SM, Papadopoulos EB, Perales MA, Jakubowski AA, Goldberg JD, Koehne G, Ceberio I, Giralt S, Zelenetz AD, Moskowitz CH, Castro-Malaspina H. Biol Blood Marrow Transplant. 2013 Mar; 20(3):354-60. Gracias a la Beca «Marcos Fernández».
- Seven novel mutations of the MSH2 gene in hereditary non-polyposis colorectal cancers (HNPCC). 2010. Artículo derivado de un trabajo anterior, el cual se ha podido concluir a lo largo del 2010, gracias a la Beca “Marcos Fernández”.
- Simplifying the detection of MUTYH mutations by high resolution melting analysis. BMC Cancer. 2010 Aug5; 10(1):408. Artículo derivado de un trabajo anterior, el cual se ha podido concluir a lo largo del 2010, gracias a la Beca “Marcos Fernández”.
- Metodologías Fosfoproteómicas Útiles en Estudios Clínicos. Inmunología. Vol.27 / Núm.1/ Enero-Marzo 2008: 36-44.
- Sequencing of two new HLA class II alleles: DRB3*0218 and DQB1*030202. Tissue Antigens. 2004 Jun; 63(6):614-6.
- Evaluation of cd7 and terminal deoxynucleotidyl transferase (tdt) expression in cd34+ myeloblasts from patients with myelodysplastic syndrome. British Journal Hematology. Leukemia Research.
- Modulation of the p38 MAPK pathway through Bcr/Abl: Implications in the cellular response to Ara-C. Biochemical Journal Immediate Publication. Published on 12 Nov. 2004 as manuscript BJ20040927.
- Chemokime receptors that mediate B cell homing to secondary lymphoid tissues are highly expresses in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination. Journal of Leukocyte Biology. Vol: 76, August 2004.
- High Molecular Response Rate and Clinical Correlation in Patients with Follicular Lymphoma Treated with Cyclophosphamide-Vincristine-Prednisone plus Interferon alfa 2b. Clinical Cancer Research. Vol. 9, 2497-2503, July 2003.